Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Tax Provisions (2018 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Tax Provisions for 5 consecutive years, with $638000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 67.94% to $638000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $810000.0 through Dec 2025, down 80.67% year-over-year, with the annual reading at $838000.0 for FY2025, 80.14% down from the prior year.
  • Tax Provisions hit $638000.0 in Q4 2025 for Protagonist Therapeutics, up from $172000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $3.3 million in Q1 2024 to a low of -$700000.0 in Q2 2024.